Results for tag: "Aneurysmal Subarachnoid Hemorrhage Drug"

Aneurysmal Subarachnoid Hemorrhage (SAH) is a type of stroke caused by bleeding in the space between the brain and the thin tissue covering it. It is a life-threatening condition that requires immediate medical attention. Treatment for SAH typically involves medications to reduce the risk of further bleeding, reduce swelling, and prevent complications. Cardiovascular drugs are commonly used to treat SAH, including anticoagulants, antiplatelet agents, and vasodilators. Anticoagulants are used to reduce the risk of further bleeding, while antiplatelet agents are used to reduce the risk of blood clots. Vasodilators are used to reduce the pressure in the brain and improve blood flow. Some companies in the Aneurysmal Subarachnoid Hemorrhage Drug market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more